Resources with keywords: XDR Shigella
Emergence of Extensively Drug-Resistant Shigellosis — United States, 2011–2023
CDC / MMWR
Logan N, Birhane MG, McDonald SL, et al.
Since 2015, a growing proportion of Shigella cases have been caused by extensively drug-resistant (XDR) Shigella species, defined as being resistant to ampicillin, azithromycin, ceftriaxone, ciprofloxacin, and trimethoprim-sulfamethoxazole. No FDA–approved oral antimicrobial agents are available to treat these XDR infections.
